rFIXFc for Immune Tolerance Induction in a Severe Hemophilia B Patient with an Inhibitor and Prior History of ITI Related Nephrotic Syndrome

被引：6

作者：

Malec, Lynn ^{[1
,2
]}

Abshire, Thomas ^{[1
,2
]}

Jobe, Shawn ^{[1
,2
]}

White, Gilbert ^{[1
,2
]}

机构：

[1] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI USA

[2] Med Coll Wisconsin, Milwaukee, WI 53226 USA

来源：

HAEMOPHILIA | 2018年 / 24卷 / 04期

关键词：

FACTOR-VIII; IGG;

D O I：

10.1111/hae.13583

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E294 / E296

页数：3

共 11 条

[1] Combination therapy for inhibitor reversal in haemophilia A using monoclonal anti-CD20 and rapamycin [J].

Biswas, Moanaro ;

Rogers, Geoffrey L. ;

Sherman, Alexandra ;

Byrnes, Barry J. ;

Markusic, David M. ;

Jiang, Haiyan ;

Herzog, Roland W. .

THROMBOSIS AND HAEMOSTASIS, 2017, 117 (01) :33-43

[2] Tolerogenic properties of the Fc portion of IgG and its relevance to the treatment and management of hemophilia [J].

Blumberg, Richard S. ;

Lillicrap, David .

BLOOD, 2018, 131 (20) :2205-2214

[3] Recombinant factor VIII Fc fusion protein for immune tolerance induction in patients with severe haemophilia A with inhibitors-A retrospective analysis [J].

Carcao, M. ;

Shapiro, A. ;

Staber, J. M. ;

Hwang, N. ;

Druzgal, C. ;

Lieuw, K. ;

Belletrutti, M. ;

Thornburg, C. D. ;

Ahuja, S. P. ;

Morales-Arias, J. ;

Dumont, J. ;

Miyasato, G. ;

Tsao, E. ;

Jain, N. ;

Pipe, S. W. .

HAEMOPHILIA, 2018, 24 (02) :245-252

[4]

ClinicalTrialsgov, ID NCT03093480 STUD

[5] Implementation of a recombinant factor IX Fc fusion protein extended-infusion desensitization protocol [J].

Clough, A. M. ;

Gilreath, J. A. ;

Mcpherson, J. . P. ;

Link, N. C. ;

Rodgers, G. M. ;

Nance, D. .

HAEMOPHILIA, 2017, 23 (03) :E227-E230

[6] Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes" [J].

De Groot, Anne S. ;

Moise, Leonard ;

McMurry, Julie A. ;

Wambre, Erik ;

Van Overtvelt, Laurence ;

Moingeon, Philippe ;

Scott, David W. ;

Martin, William .

BLOOD, 2008, 112 (08) :3303-3311

[7]

DiMichele D, 2007, BR J HAEMTOL, V138, pe294

[8] Rituximab for treatment of inhibitors in haemophilia A A Phase II Study [J].

Leissinger, Cindy ;

Josephson, Cassandra D. ;

Granger, Suzanne ;

Konkle, Barbara A. ;

Kruse-Jarres, Rebecca ;

Ragni, Margaret V. ;

Journeycake, Janna M. ;

Valentino, Leonard ;

Key, Nigel S. ;

Gill, Joan C. ;

McCrae, Keith R. ;

Neufeld, Ellis J. ;

Manno, Catherine ;

Raffini, Leslie ;

Saxena, Kapil ;

Torres, Marcela ;

Marder, Victor ;

Bennett, Carolyn M. ;

Assmann, Susan F. .

THROMBOSIS AND HAEMOSTASIS, 2014, 112 (03) :445-458

[9]

Liu T, 2012, HAEMOPHILIA, V18, P41

[10] Extended half-life factor VIII for immune tolerance induction in haemophilia [J].

Malec, L. M. ;

Journeycake, J. ;

Ragni, M. V. .

HAEMOPHILIA, 2016, 22 (06) :E552-E554

← 1 2 →